Report Highlights
Did you know RXinsider has its own Pharmacy500 Stock ETF portfolio?
Explore RXinsider’s latest market report, featuring a comprehensive Q1 breakdown:
– A closer look at the Pharmacy500 ETF stock portfolio
– Market performance analysis for last quarter, YTD, and all-time
– Benchmark comparisons (S&P 500, Nasdaq, etc.)
The objective of this report is to educate Pharmacy500 professionals, pharmacy leadership, and other stakeholders on key trends within the supply chain as it relates to publicly traded Pharmacy500 companies serving the pharmacy market.
What is RXinsider’s Pharmacy500 Stock ETF?
RXinsider’s Pharmacy500 Stock ETF is a stock portfolio comprised of the largest publicly traded companies in the Pharmacy500. This ETF (Exchange-Traded Fund) is for educational and entertainment purposes only and is not officially registered with the SEC.
What is the history and purpose of the ETF?
On 11/1/2024, RXinsider invested $10,000 in the stock of 11of the largest companies with a U.S. market presence on the Pharmacy500 list with the goal of tracking their collective performance over time and sharing the results with the pharmacy market.
We also wanted to have a little fun and compare the quarterly and annual results to other investing benchmarks such as the S&P500, NASDAQ, and DOW. We felt pharmacy professionals, pharmacists, and pharmacy students would find this information both interesting and educational.
What is the methodology for selecting the ETF companies?
More than 40 companies in the Pharmacy500 are publicly traded companies (the public can purchase company stock). RXinsider selected the Pharmacy500 companies with the greatest market cap combined with a significant proportion of their business focused on pharmacy.
Please note that stock holdings in the ETF are proportional to the company’s market cap (its overall value). For example, a greater percentage of the ETF is invested in McKesson vs. Premier due to McKesson’s larger market cap. Companies such as CVS Health are not included because they are not a Pharmacy500 company.
The information and analysis herein do not constitute advice of any kind, are not intended to be used for investment purposes, and neither RXinsider nor any of its subsidiaries or their respective officers, directors, shareholders, employees or agents accept any responsibility or liability with respect to the use of or reliance on any information or analysis contained in this document.
Pharmacy500 Market Intelligence Reports
The objective of RXinsider’s weekly Market Intelligence Reports is to educate Pharmacy500 professionals, pharmacy leadership, and other stakeholders on key trends within the supply chain as it relates to the pharmacy industry.
Learn more about RXinsider’s weekly Market Intelligence Reports on our website: RXinsider.com/pharmacy_market_intelligence
